Article Information
- Received October 26, 2011
- Revision received February 21, 2012
- Accepted March 21, 2012
- First published May 9, 2012.
- Version of record published May 9, 2012.
Author Information
Author contributions
Author contributions: M.C.K., Q.C., X.L., and P.C. designed research; M.C.K., Q.C., and A.P. performed research; M.C.K., X.L., and P.C. contributed unpublished reagents/analytic tools; M.C.K., Q.C., A.P., X.L., and P.C. analyzed data; M.C.K., Q.C., and P.C. wrote the paper.
Disclosures
- Received October 26, 2011.
- Revision received February 21, 2012.
- Accepted March 21, 2012.
This work was supported by National Institutes of Health (NIH)–National Institute on Deafness and Other Communication Disorders Grant R01 DC05213 and in part by the National Basic Research Program of China (973 Program) Grant 2012CB967902 and Natural Science Foundation of China Grant 81028003/H1305 (P.C.), and NIH–National Institute of General Medical Sciences Training Grant 5T32GM008605-12 (M.K.). The study was supported in part by the Neuronal Imaging Core of the Emory Neuroscience National Institute of Neurological Disorders and Stroke Core Facilities grant (P30NS055077). The Emory transgenic core staff assisted with generation of the TgAtoh1 mouse line. We thank the members of the Chen laboratory for helpful discussion, Dr. Yibo Huang for assistance with some of the experiments, Dr. Amy Kiernan for advice on doxycycline administration, Dr. James Bartle for the Espin antibody, and Dr. Jian Zuo and Dr. Zhiyong Liu for critical review of the manuscript.
The authors declare no competing financial interests.
- Correspondence should be addressed to Ping Chen, Department of Cell Biology, Emory University, 615 Michael Street, Atlanta, GA 30322. ping.chen{at}emory.edu
Online Impact
Article usage
In this issue
